These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3492258)

  • 1. Serum bone gla-protein in multiple myeloma.
    Bataille R; Delmas P; Sany J
    Cancer; 1987 Jan; 59(2):329-34. PubMed ID: 3492258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Edouard C; Meunier PJ
    J Clin Invest; 1986 Mar; 77(3):985-91. PubMed ID: 3485113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
    de la Piedra C; Toural V; Rapado A
    Scand J Clin Lab Invest; 1987 Oct; 47(6):587-92. PubMed ID: 3499657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications.
    Bataille R; Delmas PD; Chappard D; Sany J
    Cancer; 1990 Jul; 66(1):167-72. PubMed ID: 2354403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
    Corso A; Arcaini L; Mangiacavalli S; Astori C; Orlandi E; Lorenzi A; Passamonti F; Klersy C; Pascutto C; Canevari-Sciorati A; Lazzarino M
    Haematologica; 2001 Apr; 86(4):394-8. PubMed ID: 11325645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bone GLA-protein in growth hormone deficient children.
    Delmas PD; Chatelain P; Malaval L; Bonne G
    J Bone Miner Res; 1986 Aug; 1(4):333-8. PubMed ID: 3509741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of serum osteocalcin to hydroxyapatite in Paget's disease of bone.
    Torres R; de la Piedra C; Rapado A
    Bone Miner; 1991 Jul; 14(1):55-65. PubMed ID: 1868269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteocalcin concentrations in patients with multiple myeloma--correlation with disease stage and survival.
    Carlson K; Ljunghall S; Simonsson B; Smedmyr B
    J Intern Med; 1992 Feb; 231(2):133-7. PubMed ID: 1541935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology].
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Presse Med; 1986 Apr; 15(14):643-6. PubMed ID: 2939433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women].
    Fang TY; Liao EY; Wu XP; Liu SP; Xie H; Zhang H; Luo XH; Cao XZ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1607-9. PubMed ID: 15569454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum osteocalcin in hyperthyroidism].
    Roiter I; Legovini P; Da Rin G; Galliazzo S; Di Virgilio R; Foscolo G; Breda F; Conte N
    Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
    Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
    Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
    Kaiser M; Mieth M; Liebisch P; Oberländer R; Rademacher J; Jakob C; Kleeberg L; Fleissner C; Braendle E; Peters M; Stover D; Sezer O; Heider U
    Eur J Haematol; 2008 Jun; 80(6):490-4. PubMed ID: 18331598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM).
    Mejjad O; Le Loët X; Basuyau JP; Ménard JF; Jego P; Grisot C; Daragon A; Grosbois B; Euller-Ziegler L; Monconduit M
    Eur J Haematol; 1996; 56(1-2):30-4. PubMed ID: 8599990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma.
    Terpos E; Christoulas D; Kastritis E; Bagratuni T; Gavriatopoulou M; Roussou M; Papatheodorou A; Eleutherakis-Papaiakovou E; Kanellias N; Liakou C; Panagiotidis I; Migkou M; Kokkoris P; Moulopoulos LA; Dimopoulos MA
    Blood Cancer J; 2016 Oct; 6(10):e482. PubMed ID: 27716740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
    Body JJ; Cleeren A; Pot M; Borkowski A
    J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.